Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for RegeneRx Biopharmaceuticals Inc. (RGRX : OTCBB)
 
 • Company Description   
RegeneRx is a biopharmaceutical company that holds over fifty world-wide patents and patent applications related to dermal, ocular, and internal wounds and tissue repair, including the treatment and prevention of cardiac and neurological injuries.

Number of Employees: 7

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.20 Daily Weekly Monthly
20 Day Moving Average: 41,404 shares
Shares Outstanding: 143.55 (millions)
Market Capitalization: $28.71 (millions)
Beta: 0.30
52 Week High: $0.32
52 Week Low: $0.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 29.03% 45.34%
12 Week -23.08% -15.43%
Year To Date 25.00% 52.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
15245 SHADY GROVE ROAD SUITE 470
-
ROCKVILLE,MD 20850
USA
ph: 301-208-9191
fax: 301-280-1996
info@regenerx.com http://www.regenerx.com
 
 • General Corporate Information   
Officers
J.J. Finkelstein - Chief Executive Officer; President and Director
Allan L. Goldstein - Chairman; Chief Scientific Officer and Director
R. Don Elsey - Director
Joseph C. McNay - Director
Mauro Bove - Director

Peer Information
RegeneRx Biopharmaceuticals Inc. (CORR.)
RegeneRx Biopharmaceuticals Inc. (RSPI)
RegeneRx Biopharmaceuticals Inc. (CGXP)
RegeneRx Biopharmaceuticals Inc. (BGEN)
RegeneRx Biopharmaceuticals Inc. (GTBP)
RegeneRx Biopharmaceuticals Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 75886X108
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 143.55
Most Recent Split Date: (:1)
Beta: 0.30
Market Capitalization: $28.71 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 375.88
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: 0.01%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -110.37
12/31/21 - -120.49
09/30/21 - -132.63
Current Ratio
03/31/22 - 2.33
12/31/21 - 2.91
09/30/21 - 3.71
Quick Ratio
03/31/22 - -
12/31/21 - 2.91
09/30/21 - 3.71
Operating Margin
03/31/22 - -2,149.78
12/31/21 - -2,092.17
09/30/21 - -1,984.79
Net Margin
03/31/22 - -2,149.78
12/31/21 - -2,092.17
09/30/21 - -1,984.79
Pre-Tax Margin
03/31/22 - -2,149.78
12/31/21 - -2,081.79
09/30/21 - -1,984.79
Book Value
03/31/22 - -0.02
12/31/21 - -0.02
09/30/21 - -0.01
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©